- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 71,634,221
- Share change
- -5,484,032
- Total reported value
- $214,185,830
- Put/Call ratio
- 31%
- Price per share
- $2.99
- Number of holders
- 127
- Value change
- -$13,154,422
- Number of buys
- 61
- Number of sells
- 54
Quarterly Holders Quick Answers
What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29664W105:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP |
13F
|
Company |
4.5%
|
11,526,100
|
$11,295,578 | — | 30 Sep 2023 | |
| Two Seas Capital LP |
13F
|
Company |
3%
|
7,672,170
|
$7,518,727 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.2%
|
5,794,029
|
$5,678,148 | — | 30 Sep 2023 | |
| BIOTECH TARGET N V |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,477,964
|
$5,575,065 | — | 24 May 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
4,741,362
|
$4,646,535 | — | 30 Sep 2023 | |
| Bellevue Group AG |
13F
|
Company |
1.6%
|
4,204,264
|
$4,120,179 | — | 30 Sep 2023 | |
| Meditor Group Ltd |
13F
|
Company |
1.5%
|
3,791,300
|
$3,715,474 | — | 30 Sep 2023 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
1.2%
|
3,189,517
|
$3,125,727 | — | 30 Sep 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.2%
|
3,097,852
|
$3,035,895 | — | 30 Sep 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.88%
|
2,264,359
|
$2,219,072 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.81%
|
2,103,780
|
$2,061,706 | — | 30 Sep 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.77%
|
1,997,071
|
$1,957,130 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.76%
|
1,967,879
|
$1,928,522 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.72%
|
1,864,332
|
$1,827,045 | — | 30 Sep 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.72%
|
1,850,000
|
$1,813,000 | — | 30 Sep 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.67%
|
1,737,636
|
$1,702,883 | — | 30 Sep 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.61%
|
1,574,136
|
$1,542,653 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.59%
|
1,536,300
|
$1,505,574 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.56%
|
1,457,935
|
$1,428,776 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.48%
|
1,231,827
|
$1,207,190 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.46%
|
1,176,996
|
$1,153,456 | — | 30 Sep 2023 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.45%
|
1,171,779
|
$1,148,343 | — | 30 Sep 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.43%
|
1,116,655
|
$1,094,000 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
970,238
|
$951,083 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.25%
|
651,548
|
$638,517 | — | 30 Sep 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.24%
|
631,947
|
$619,308 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.23%
|
597,840
|
$585,883 | — | 30 Sep 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.2%
|
519,129
|
$508,746 | — | 30 Sep 2023 | |
| Parallel Advisors, LLC |
13F
|
Company |
0.18%
|
478,000
|
$468,440 | — | 30 Sep 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.16%
|
413,704
|
$405,430 | — | 30 Sep 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
366,298
|
$358,972 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.12%
|
310,778
|
$304,562 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
302,449
|
$296,400 | — | 30 Sep 2023 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.11%
|
289,123
|
$283,341 | — | 30 Sep 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.1%
|
268,484
|
$263,114 | — | 30 Sep 2023 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.1%
|
254,265
|
$249,180 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0.1%
|
253,061
|
$248,000 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
228,710
|
$224,135 | — | 30 Sep 2023 | |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP |
13F
|
Company |
0.09%
|
222,482
|
$218,989 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.08%
|
206,156
|
$202,000 | — | 30 Sep 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.08%
|
202,985
|
$198,925 | — | 30 Sep 2023 | |
| SILVERBACK ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
100,000
|
$197,672 | — | 30 Sep 2023 | |
| NJ State Employees Deferred Compensation Plan |
13F
|
Company |
0.08%
|
195,125
|
$191,223 | — | 30 Sep 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.07%
|
181,597
|
$178,000 | — | 30 Sep 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.07%
|
175,473
|
$171,964 | — | 30 Sep 2023 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.06%
|
157,747
|
$154,592 | — | 30 Sep 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.05%
|
136,346
|
$131,000 | — | 30 Sep 2023 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.04%
|
116,021
|
$113,701 | — | 30 Sep 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.04%
|
112,802
|
$110,546 | — | 30 Sep 2023 | |
| Richard Bartram |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
241,751
mixed-class rows
|
$103,025 | — | 14 Mar 2022 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q4 2023
As of 31 Dec 2023,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,634,221 shares.
The largest 10 holders included
WASATCH ADVISORS LP, Two Seas Capital LP, VANGUARD GROUP INC, Bellevue Group AG, Meditor Group Ltd, MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, TWO SIGMA INVESTMENTS, LP, and TWO SIGMA ADVISERS, LP.
This page lists
128
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
120
Q4 2023 holders
127
Holder diff
7
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.